SCHUMER, GILLIBRAND ANNOUNCE OVER $1 MILLION IN FEDERAL FUNDING FOR MEDICAL RESEARCH IN UPSTATE NY
Grants Awarded To Buffalo, Rensselaer Medical Institutions
Funding Will Support Cancer Detection & Diagnosis, Vision Research
Schumer, Gillibrand: Federal Investment Will Ensure NY Remains On Forefront Of Medicine
U.S. Senator Charles E. Schumer and U.S. Senator Kirsten Gillibrand today announced $1,138,736 in federal funding for cancer research at the Roswell Park Cancer Institute in Buffalo and vision research at the Regenerative Research Foundation in Rensselaer. The funding was allocated though grants awarded by the National Cancer Institute (NCI) and National Eye Institute (NEI).
“Upstate New York has long been a hub for lifesaving and cutting-edge medical research,” said Senator Schumer. “This federal funding will help world-class institutions, such as Roswell Park and the Regenerative Research Foundation, combat health issues using science and innovation. I will always fight to deliver the funding that fuels the work of Upstate New York’s vital medical research sector.”
“Supporting medical and research institutions is vital to treating and understanding serious diseases and health concerns,” said Senator Gillibrand. “Roswell Park Cancer Institute in Buffalo and the Regenerative Research Foundation in Rensselaer are developing breakthrough solutions in cancer detection and diagnosis and vision research. These world renowned institutes keep Upstate New York at the forefront of innovative research and I will always fight to ensure they have the funding needed to thrive.”
NCI and NEI are part of the National Institutes for Health (NIH), which is under the purview of the U.S. Department of Health and Human Services (HHS). NIH is the primary federal agency responsible for conducting medical research.
A breakdown of the funding appears below:
Roswell Park Cancer Institute (Buffalo) $493,265
Regenerative Research Foundation (Rensselaer) $645,471